Cornelia Kruse-Muller

Title: Cornelia Kruse-Muller: Innovator in Nucleic Acid Detection

Introduction

Cornelia Kruse-Muller is a distinguished inventor based in Tutzing, Germany. She has made significant contributions to the field of biochemistry, particularly in the detection of nucleic acids. With a total of 2 patents to her name, her work has advanced methodologies in medical diagnostics.

Latest Patents

Her latest patents include a method for the sensitive detection of nucleic acids. This innovative technique involves the reaction of a sample with labeled nucleotide triphosphates and enzymes that catalyze the production of a labeled nucleic acid. The process allows for the specific detection of nucleic acids in a sample, enhancing the accuracy of diagnostics. Another notable patent is a process for the determination of total bilirubin in body fluid samples. This method utilizes subtilisin to liberate bilirubin from albumin, combined with bilirubin oxidase to measure total bilirubin content effectively.

Career Highlights

Cornelia is currently associated with Boehringer Mannheim GmbH, where she continues to push the boundaries of research in her field. Her work has been instrumental in developing reliable diagnostic tools that are crucial for patient care.

Collaborations

Throughout her career, Cornelia has collaborated with notable colleagues, including Joachim Siedel and Joachim Ziegenhorn. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Cornelia Kruse-Muller exemplifies the spirit of innovation in the field of biochemistry. Her contributions to nucleic acid detection and bilirubin measurement are significant advancements that continue to impact medical diagnostics.